Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01635556
Other study ID # H2012:128
Secondary ID
Status Completed
Phase N/A
First received May 23, 2012
Last updated May 3, 2017
Start date September 2012
Est. completion date January 2016

Study information

Verified date November 2014
Source University of Manitoba
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this pilot project is to offer outpatient Dialectical Behavior Therapy (DBT) treatment as described in Linehan's text (1993), which is considered an effective treatment of borderline personality disorder. This treatment consists of weekly individual psychotherapy, weekly group skills training, 24 hour telephone consultation, and weekly team consultation meetings for therapists. The investigators program is able to offer all of these components except the 24 hour phone consultation (which has been modified due to employment/union guidelines of interdisciplinary staff working within the investigators health care system). This project intends to offer the treatment for a period of 6 months.

As such, this proposed research project seeks to assess the feasibility of implementing an outpatient DBT program within a public health care setting in Canada. This study also aims to evaluate this DBT program for clinical effectiveness in its modified format. Specifically, the investigators will examine relevant outcomes related to patient functioning (e.g., depression, self-harm and suicidal behaviors, and admissions to hospital/ER visits) and improvement (e.g., improved quality of life, meeting work/employment goals) pre and post completion of this 6 month treatment program.

The investigators hypotheses are that each patient will show improvement in all outcome variables (e.g., improved mood and quality of life, decreased self-harm, decreased ER visits and hospitalization visits, etc). The investigators also hypothesize that the investigators modified program will produce comparable results to those from studies of standard outpatient DBT.


Description:

Standard DBT includes four modes of intervention: weekly individual psychotherapy; weekly skills group; 24 hour phone consultation to the patient; and consultation team meetings. The skills group is focused on teaching skills (mindfulness, emotional regulation, distress tolerance, and interpersonal effectiveness), and facilitating the replacement of maladaptive behaviors with adaptive behaviors (Neasciu, Rizvi, & Linehan, 2010). Individual therapy sessions focus on reducing target problem behaviors (e.g., life threatening behavior, therapy interfering behavior, quality of life interfering behaviors). Phone consultation is to aid the client in generalizing skill use to their every day life. The consultation team meetings are for the therapists, to provide support, and to aid therapists in staying adherent to a DBT frame of treatment.

This project will be utilizing a convenience sample. Patients are referred to the program by their psychiatrist/family doctor. They are assessed by a Clinical Psychologist to determine if they meet criteria for a diagnosis of Borderline Personality Disorder via clinical interview and a semi-structured diagnostic interview. They must also meet the inclusion/exclusion criteria for participation in the program, which are as follows:

Inclusion Criteria

- 18 years or older

- Borderline personality disorder diagnosis

- Chronic suicidal ideation or parasuicidal acts, or other self-destructive, impulsive behaviors

- Must be willing to sign DBT contract and commit to 6-month duration of treatment of both individual therapy and skills training group.

Exclusion Criteria

- Active psychosis

- Severe developmental delays, cognitive impairment or learning disabilities

- No violent behaviors will be tolerated. Patients with a history of dangerous or aggressive behaviors towards others, history of medical harm to previous therapists may not be considered.

Following this, they must agree to participate in the program and to the program requirements (weekly individual therapy, skills group, etc). Once this has occurred, they will be approached by a research assistant to discuss with them their voluntary participation in this research study. Once consent is provided, the patient will complete several baseline measures. These same measures will be completed at post treatment (6 months) and then again at 12 months and 18 months for follow-up. Each patient will also complete a weekly diary card, which asks them to record several aspects of daily functioning, as well as self-harm urges and behaviors, and use of skills taught in DBT.


Recruitment information / eligibility

Status Completed
Enrollment 16
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Diagnosis of Borderline Personality Disorder

- Chronic suicidal ideation or parasuicidal acts, or other self-destructive, impulsive behaviors

- Must be enrolled in dialectical behavior therapy program

Exclusion Criteria:

- Active psychosis

- Severe developmental delays, cognitive impairment or learning disabilities

- History of or current violent/aggressive behaviors

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Dialectical Behavior therapy
Weekly psychotherapy of both individual and group sessions

Locations

Country Name City State
Canada Victoria General Hospital Winnipeg Manitoba

Sponsors (1)

Lead Sponsor Collaborator
University of Manitoba

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Quality of Life Enjoyment and Satisfaction Questionnaire This measure assesses the degree of enjoyment and satisfaction experienced during the past week in several areas: physical health, feelings, work, household duties, school, leisure time, and social relationships. Baseline
Primary Quality of Life Enjoyment and Satisfaction Questionnaire This measure assesses the degree of enjoyment and satisfaction experienced during the past week in several areas: physical health, feelings, work, household duties, school, leisure time, and social relationships. Change - baseline to 6 months
Primary Quality of Life Enjoyment and Satisfaction Questionnaire This measure assesses the degree of enjoyment and satisfaction experienced during the past week in several areas: physical health, feelings, work, household duties, school, leisure time, and social relationships. Change - 6 months to 12 months
Primary Quality of Life Enjoyment and Satisfaction Questionnaire This measure assesses the degree of enjoyment and satisfaction experienced during the past week in several areas: physical health, feelings, work, household duties, school, leisure time, and social relationships. Change - 12 months to 18 months
Secondary Borderline Symptom List 23 Baseline
Secondary Borderline Symptom List 23 Change - baseline to 6 months
Secondary Borderline Symptom List 23 Change - 6 months to 12 months
Secondary Borderline Symptom List 23 Chabge - 12 months to 18 months
See also
  Status Clinical Trial Phase
Recruiting NCT04856449 - DBT Skills Plus EMDR for BPD and Trauma N/A
Active, not recruiting NCT04587518 - Five Factor Model Treatment for Borderline Personality Disorder N/A
Recruiting NCT05651295 - A Precision Medicine Approach to Target Engagement for Emotion Regulation N/A
Completed NCT03677037 - The Short-Term MBT Project Phase 3
Not yet recruiting NCT05989529 - Delving Into Borderline Personality Disorder Clinical Trial Experiences
Completed NCT02068326 - MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial N/A
Completed NCT02518906 - Evaluation of AIT Study N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Terminated NCT02149823 - Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations Phase 1
Completed NCT02108990 - Acetaminophen and Social Processes Phase 2
Completed NCT02988037 - Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study N/A
Not yet recruiting NCT01683136 - Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder N/A
Completed NCT02397031 - Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder N/A
Terminated NCT01212588 - Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD) Phase 2
Terminated NCT01103180 - Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder Phase 2
Terminated NCT00539188 - N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD Phase 2
Recruiting NCT05398627 - Neurofeedback for Borderline Personality Disorder N/A
Recruiting NCT03994510 - SHame prOpensity in bOrderline Personality Disorder N/A
Recruiting NCT06005129 - Personality Change Study for Borderline Personality Disorder N/A
Recruiting NCT06406972 - Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care